3.9 Article

Doxycycline-induced idiopathic intracranial hypertension in a patient with Lyme disease

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.JAA.0000731504.17394.29

Keywords

idiopathic intracranial hypertension; pseudotumor cerebri; doxycycline; Lyme disease; vision loss; disseminated

Ask authors/readers for more resources

Doxycycline is commonly used to treat Lyme disease but can lead to a rare adverse reaction called idiopathic intracranial hypertension (IIH). This article reviews a case of disseminated Lyme disease complicated by doxycycline-induced IIH, discussing the pathophysiology, presentation, diagnosis, and treatment of the condition.
Doxycycline is widely used to treat early and disseminated Lyme disease. Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a rare but serious adverse reaction to this medication. This article reviews the pathophysiology, presentation, diagnosis, and treatment of a patient with disseminated Lyme disease complicated by doxycycline-induced IIH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available